#CRBP Possible Targets : $2.60 - 3.90 - 7.86 - 9.90

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.

Targets : $2.60 - 3.90 - 7.86 - 9.90


**Disclaimer - not financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
I would appreciate your feedback on my analysis. Do not view this idea as a recommendation for trading or investing.